19 Nov 2018 | 9:29 AM
 

Welcure Drugs & Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 524661 | NSE Symbol:
0.54
0.02
(3.85 %)
14 Nov 2018 | 04:01 PM
Change company
  • Open (Rs)
    0.51
  • Prev. close (Rs.)
    0.52
  • High (Rs.)
    0.54
  • Low (Rs.)
    0.51
  • 52W H (Rs.)
    1.41
  • 52W L (Rs.)
    0.51
  • Volume
    14608
  • MCap (Rs in Cr.)
    0.73
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-1.31
Operating Margin (%)
-293.07
Gross Profit Margin (%)
-391.39
Net Profit Margin (%)
-112.78
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

16 Nov 2018 - 14:29:00-Glenmark Pharmaceuticals Friday said it has received approval from the US health regulator for Terif...
16 Nov 2018 - 12:07:00-Shares of Shilpa Medicare rallied nearly 9 per cent on the Bombay Stock Exchange after drug maker sa...
16 Nov 2018 - 11:59:00-The company reported standalone net loss during the quarter stood at Rs 0...
16 Nov 2018 - 10:41:00-The company reported standalone net loss during the quarter stood at Rs 0...

Announcements

25-Oct-2018
Welcure Drugs & - Revised Compliance Certificate From Practicing Company Secretary Under Regulation 40(9) & 40(10) Of SEBI (
11-Oct-2018
Welcure Drugs & - Announcement under Regulation 30 (LODR)-Newspaper Publication
08-Oct-2018
Welcure Drugs & - Outcome of Board Meeting
08-Oct-2018
Welcure Drugs & - Un-Audited Results For The Half Year And Quarter Ended 30.09.2018
08-Oct-2018
Welcure Drugs & - Announcement Under Regulation 30 Of SEBI ( Listing Obligations And Disclosure Requirement) Regulations 201

Religare Research

16 Nov 2018 | 07:00 PM
Incorporated in 1962, Tata Global Beverages Ltd is amongst the world's largest tea companies along w...
16 Nov 2018 | 07:00 PM
Nifty managed to end in green for the third successive week amid volatility and settled at 10,682.20...
16 Nov 2018 | 03:05 PM
Reliance Nippon Life Asset Management (RNAM) reported a net profit growth of 10.4% YoY at Rs. 111 cr...
16 Nov 2018 | 10:18 AM
• Gold prices edge higher amid Brexit turmoil • Natural gas prices plunge 18 percent in a second wil...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors14.12%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others13.22%

Peer Group

Company Intraday Graph
 Hester Biosciences Ltd.
1,141.00(1.33)
3572
 DIL Ltd.
955.00(-3.72)
3299
 TTK Healthcare Ltd.
785.00(-3.84)
3392
 Novartis India Ltd.
714.00(1.42)
2647

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Welcure Drugs & Pharmaceuticals Ltd.0.02-0.11-0.67
NIFTY(S&P CNX)141.15-659.15-15.20
BSE SENSEX460.34-2,040.74234.94
BSE 500201.69-1,047.43-488.09

Corporate Details

Key Personal
M L Bhateja
Director & CFO
Rashi Aggarwal
Woman Director
Sudhir Chandra
Managing Director
Key Address
Registered Office
B- 9 &10 Laxmi Towers LSC C Block Saraswati Vihar,New Delhi,Delhi

Tel:011-27011428, Fax:011-27023256

investor.welcure@gmail.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)